A few months ago, India’s drug regulator Central Drugs Standard Control Organization (CDSCO) approved the commercial use of CAR-T cell therapy. Therapy involves genetically reprogramming the patient’s immune system to fight the cancer.
A few months ago, India’s drug regulator Central Drugs Standard Control Organization (CDSCO) approved the commercial use of CAR-T cell therapy. Therapy involves genetically reprogramming the patient’s immune system to fight the cancer.
